APA (7th ed.) Citation

Frezza, A. M., Beale, T., Bomanji, J., Jay, A., Kalavrezos, N., Dileo, P., . . . Strauss, S. J. (2014). Is [F-18]-fluorodeoxy-D-glucose positron emission tomography of value in the management of patients with craniofacial bone sarcomas undergoing neo-adjuvant treatment? BMC Cancer, 14(1), 1. https://doi.org/10.1186/1471-2407-14-23

Chicago Style (17th ed.) Citation

Frezza, Anna Maria, Tim Beale, Jamshed Bomanji, Amrita Jay, Nicholas Kalavrezos, Palma Dileo, Jeremy Whelan, and Sandra J. Strauss. "Is [F-18]-fluorodeoxy-D-glucose Positron Emission Tomography of Value in the Management of Patients with Craniofacial Bone Sarcomas Undergoing Neo-adjuvant Treatment?" BMC Cancer 14, no. 1 (2014): 1. https://doi.org/10.1186/1471-2407-14-23.

MLA (9th ed.) Citation

Frezza, Anna Maria, et al. "Is [F-18]-fluorodeoxy-D-glucose Positron Emission Tomography of Value in the Management of Patients with Craniofacial Bone Sarcomas Undergoing Neo-adjuvant Treatment?" BMC Cancer, vol. 14, no. 1, 2014, p. 1, https://doi.org/10.1186/1471-2407-14-23.